Search Within

Malin Lisa Hultcrantz

Formats
  1. Meeting Abstract (178)
  2. Journal Article (70)
  3. Research Letter (10)
  4. Guidelines (6)
  5. Correspondence (3)
  6. Review (3)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (271)
  2. Department of Medicine (271)
  3. Hematologic Malignancies, Division of (271)
  4. Myeloma (271)
  5. Sloan Kettering Institute Postdocs (271)
  6. Hematologic Malignancies Research (188)

More Groups

People
  1. Sham Mailankody (157)
  2. Neha Korde (154)
  3. Alexander Lesokhin (149)
  4. Hani Hassoun (143)
  5. Urvi Shah (134)
  6. Sergio Giralt (128)

More People

Years
  1. 2025 (12)
  2. 2024 (46)
  3. 2023 (51)
  4. 2022 (52)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (104)
  2. Clinical Lymphoma, Myeloma and Leukemia (50)
  3. Journal of Clinical Oncology (17)
  4. Blood Cancer Journal (14)
  5. Haematologica (10)
  6. Blood Advances (7)

More Publications

Publishers
  1. American Society of Hematology (111)
  2. Elsevier Inc. (56)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (10)
  6. American Association for Cancer Research (6)

More Publishers

Results (271)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms—a nationwide population-based study of 342 pregnancies in Sweden
    Journal Article

    Landtblom, A. R.; Andersson, T. M. L.; Johansson, A. L. V.; Wendel, S. B.; Lundberg, F. E.; Samuelsson, J.; Björkholm, M.; Hultcrantz, M.
    Leukemia (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
    Journal Article

    Long, T. E.; Indridason, O. S.; Palsson, R.; Rognvaldsson, S.; Love, T. J.; Thorsteinsdottir, S.; Sverrisdottir, I. S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
    Research Letter

    Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Capture rate of V(D)J sequencing for minimal residual disease detection in multiple myeloma
    Journal Article

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Jacob, A.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Smith, E. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Refractive shifts and changes in corneal curvature associated with antibody-drug conjugates
    Journal Article

    Canestraro, J.; Hultcrantz, M.; Modi, S.; Hamlin, P. A.; Shoushtari, A. N.; Konner, J. A.; Tew, W. P.; Iyengar, N. M.; Heinemann, M.; Abramson, D. H.; more...
    Cornea (2022)

    Fulltext@MSK | Save
  • Nutrition perceptions, needs and practices among patients with plasma cell disorders
    Research Letter

    Malik, M. A.; Sweeney, N. W.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P. A.; Mailankody, S.; Korde, N.; Tan, C. R.; Hassoun, H.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
    Journal Article

    Piedra, K.; Peterson, T.; Tan, C.; Orozco, J.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Lesokhin, A.; Shah, U.; Lu, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Multiple myeloma, version 3.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Callander, N. S.; Baljevic, M.; Adekola, K.; Anderson, L. D. Jr; Campagnaro, E.; Castillo, J. J.; Costello, C.; Devarakonda, S.; Elsedawy, N.; Faiman, M.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save